$QIND
Quality Industrial Corp. Stock $qind

$qind Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000166357723000151 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$18.16M	$28.26M	$65.00
YoY Change
Cost Of Revenue	$12.70M	$18.62M	$43.93M
YoY Change
Gross Profit	$5.453M	$9.640M	$21.67M
YoY Change
Gross Profit Margin	30.03%	34.11%	33341741.54%
Selling, General & Admin	$2.431M	$4.124M	$11.22M
YoY Change		5189.97%	3282.3%
% of Gross Profit	44.59%	42.78%	51.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$171.0K	$171.0K
YoY Change
% of Gross Profit		1.77%	0.79%
Operating Expenses	$2.431M	$4.124M	$11.47M
YoY Change	1218.35%	2721.38%
Operating Profit	$3.022M	$5.516M	$10.20M
YoY Change	-1738.37%	-3873.69%	-297.12%
Interest Expense	-$971.4K	-$3.023M	-$3.840M
YoY Change	-96086.96%	269066.16%	86218.72%
% of Operating Profit	-32.15%	-54.8%	-37.65%
Other Income/Expense, Net	-$990.9K	-$3.213M	-$4.148M
YoY Change	6763.22%	286022.71%	92940.35%
Pretax Income	$2.031M		$6.773M
YoY Change			-230.77%
Income Tax
% Of Pretax Income
Net Earnings	$2.031M	$2.566M	$6.773M
YoY Change	-1294.61%	-1841.93%	-230.77%
Net Earnings / Revenue	11.18%	9.08%	10420412.31%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.02	$0.00	$0.07
COMMON SHARES
Basic Shares Outstanding	102.9M shares	102.9M shares	102.9M shares
Diluted Shares Outstanding			102.9M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.733M		$2.816M
YoY Change			17881.1%
Cash & Equivalents	$1.230M	$1.313M	$1.313M
Short-Term Investments	$1.503M		$1.503M
Other Short-Term Assets	$109.0M	$110.3M	$12.31M
YoY Change		61960212.36%	6841155.56%
Inventory	$45.83M	$1.203M	$58.64M
Prepaid Expenses	$7.540M	$7.540M
Receivables	$48.55M	$37.84M	$37.84M
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$110.2M	$111.6M	$111.6M
YoY Change		704591.05%	704457.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$33.41M		$32.70M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$89.79M	$89.09M
YoY Change		42264.83%
Total Long-Term Assets	$89.79M	$89.09M	$89.09M
YoY Change		42264.83%	42265.43%
TOTAL ASSETS
Total Short-Term Assets	$110.2M	$111.6M	$111.6M
Total Long-Term Assets	$89.79M	$89.09M	$89.09M
Total Assets	$200.0M	$200.7M	$200.7M
YoY Change		88650.8%	88650.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.92M	$43.34M	$44.55M
YoY Change			21378.84%
Accrued Expenses	$887.2K	$1.206M	$836.4K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$19.72M		$18.22M
YoY Change			4599.35%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$141.8M	$144.7M	$144.7M
YoY Change		24211.4%	24211.27%
LONG-TERM LIABILITIES
Long-Term Debt	$13.67M		$1.100M
YoY Change
Other Long-Term Liabilities	$28.01M	$28.03M	$28.03M
YoY Change
Total Long-Term Liabilities	$29.31M	$29.13M	$29.13M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$141.8M	$144.7M	$144.7M
Total Long-Term Liabilities	$29.31M	$29.13M	$29.13M
Total Liabilities	$171.1M	$173.8M	$197.5M
YoY Change		29105.85%	33078.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.423M	-$9.438M
YoY Change		-26.05%
Common Stock	$102.9K	$102.9K
YoY Change		8.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.91M	$3.235M	$3.235M
YoY Change
Total Liabilities & Shareholders Equity	$200.0M	$200.7M	$200.7M
YoY Change		88650.8%	88650.8%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$2.031M	$2.566M	$6.773M
YoY Change	-1294.61%	-1841.93%	-230.77%
Depreciation, Depletion And Amortization		$171.0K	$171.0K
YoY Change
Cash From Operating Activities	$2.206M		-$44.45M
YoY Change	-4171.22%		10761.88%
INVESTING ACTIVITIES
Capital Expenditures	$704.1K		$88.88M
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$704.1K		-$88.88M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$278.9K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.584M		$45.73M
YoY Change	-3099.52%		11182.94%
NET CHANGE
Cash From Operating Activities	$2.206M		-$44.45M
Cash From Investing Activities	-$704.1K		-$88.88M
Cash From Financing Activities	-$1.584M		$45.73M
Net Change In Cash	-$82.67K		$1.297M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	$2.206M		-$44.45M
Capital Expenditures	$704.1K		$88.88M
Free Cash Flow	$1.502M		-$133.3M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Revenues Revenues		usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2021Q4	us-gaap	Gross Profit GrossProfit		usd
CY2021	us-gaap	Gross Profit GrossProfit		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001393781
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross		usd
CY2021Q4	QIND	Capital Work In Progress CapitalWorkInProgress		usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross		usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross		usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2021Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent		usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2021Q4	us-gaap	Revenues Revenues		usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees		usd
CY2021Q4	us-gaap	Professional Fees ProfessionalFees		usd
CY2021	us-gaap	Professional Fees ProfessionalFees		usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2021Q4	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt		usd
CY2021	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt		usd
CY2022Q4	us-gaap	Entertainment License Agreement For Program Material Not In Film Group Impairment EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment		usd
CY2021Q4	us-gaap	Entertainment License Agreement For Program Material Not In Film Group Impairment EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment		usd
CY2021	us-gaap	Entertainment License Agreement For Program Material Not In Film Group Impairment EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment		usd
CY2022Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2021Q4	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2021Q4	us-gaap	Depreciation Depreciation		usd
CY2021	us-gaap	Depreciation Depreciation		usd
CY2021Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022Q4	QIND	Gain On Forgiveness Of Accrued Salary GainOnForgivenessOfAccruedSalary		usd
CY2021Q4	QIND	Gain On Forgiveness Of Accrued Salary GainOnForgivenessOfAccruedSalary		usd
CY2021	QIND	Gain On Forgiveness Of Accrued Salary GainOnForgivenessOfAccruedSalary		usd
CY2021	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest		usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities		usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2021	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax		usd
CY2021	us-gaap	Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Amortization Expense Period Increase Decrease DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAmortizationExpensePeriodIncreaseDecrease		usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2021	us-gaap	Professional Fees ProfessionalFees		usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2021	us-gaap	Depreciation Depreciation		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56239
CY2022	dei	Entity Registrant Name EntityRegistrantName	QUALITY INDUSTRIAL CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2675388
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	315 Montgomery Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94104
CY2022	dei	City Area Code CityAreaCode	800
CY2022	dei	Local Phone Number LocalPhoneNumber	706-0806
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	8214697	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	102883709	shares
CY2022	dei	Auditor Name AuditorName	Pipara & Co LLP
CY2022	dei	Auditor Firm AuditorFirmId	6841
CY2022	dei	Auditor Location AuditorLocation	Ahmedabad, India
CY2022Q4	us-gaap	Cash Cash	1312565	usd
CY2021Q4	us-gaap	Cash Cash	15659	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110289356	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	178	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	111601921	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	15837	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	210293	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1365585	usd
CY2022Q4	QIND	Capital Work In Progress CapitalWorkInProgress	1884569	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	156370	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	17390067	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	11906654	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	56387027	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	89090272	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	210293	usd
CY2022Q4	us-gaap	Assets Assets	200692193	usd
CY2021Q4	us-gaap	Assets Assets	226130	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	44551407	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	207421	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	100134714	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	387716	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	144686121	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	595137	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1100000	usd
CY2022Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	28028680	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29128680	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102883709	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94738209	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	102886	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	94740	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12174975	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11904190	usd
CY2022Q4	QIND	Stock Payable StockPayable	395101	usd
CY2021Q4	QIND	Stock Payable StockPayable	395101	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9438315	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12763038	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	23642745	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26877392	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-369007	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	200692193	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	226130	usd
CY2022Q4	us-gaap	Revenues Revenues	28260873	usd
CY2022	us-gaap	Revenues Revenues	65	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	18620991	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	43931541	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	9639882	usd
CY2022	us-gaap	Gross Profit GrossProfit	21672132	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	255111	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	68210	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4843433	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4123956	usd
CY2021Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	77958	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11216017	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	331609	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	4123956	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	146168	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	11471128	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	5175042	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	5515926	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-146168	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	10201004	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-5175042	usd
CY2022Q4	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	19408	usd
CY2022	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	31855	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	-3022736	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	-1123	usd
CY2022	us-gaap	Interest Expense InterestExpense	-3840320	usd
CY2021	us-gaap	Interest Expense InterestExpense	-4449	usd
CY2022	us-gaap	Entertainment License Agreement For Program Material Not In Film Group Impairment EntertainmentLicenseAgreementForProgramMaterialNotInFilmGroupImpairment	104550	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	9	usd
CY2022Q4	us-gaap	Depreciation Depreciation	171014	usd
CY2022	us-gaap	Depreciation Depreciation	171014	usd
CY2022Q4	us-gaap	Other Expenses OtherExpenses	-3213158	usd
CY2021Q4	us-gaap	Other Expenses OtherExpenses	-1123	usd
CY2022	us-gaap	Other Expenses OtherExpenses	-4147739	usd
CY2021	us-gaap	Other Expenses OtherExpenses	-4458	usd
CY2022Q4	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	262932	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	262932	usd
CY2022	QIND	Gain On Forgiveness Of Accrued Salary GainOnForgivenessOfAccruedSalary	457071	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	2565700	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-147291	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6773268	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5179500	usd
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102883709	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95118858	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102883709	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95118858	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3041	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	110229	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4720214	usd
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-1	usd
CY2021	QIND	Receivable With Imputed Interest Value ReceivableWithImputedInterestValue	3022	usd
CY2021	QIND	Net Income Loss Inludes Other Amounts NetIncomeLossInludesOtherAmounts	-169990	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-369007	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	57824	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	104550	usd
CY2022Q1	QIND	Receivable With Imputed Interest Value ReceivableWithImputedInterestValue	745	usd
CY2022Q1	QIND	Net Income Loss Inludes Other Amounts NetIncomeLossInludesOtherAmounts	169990	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-375878	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	38742	usd
CY2022Q2	QIND	Receivable With Imputed Interest Value ReceivableWithImputedInterestValue	753	usd
CY2022Q2	QIND	Receivable With Imputed Interest Reclassed To Accrued Interest Value ReceivableWithImputedInterestReclassedToAccruedInterestValue	-6283	usd
CY2022Q2	QIND	Net Income Loss Inludes Other Amounts NetIncomeLossInludesOtherAmounts	1946443	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1603777	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	82600	usd
CY2022Q3	QIND	Net Income Loss Inludes Other Amounts NetIncomeLossInludesOtherAmounts	2431115	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4117492	usd
CY2022Q4	QIND	Net Income Loss Inludes Other Amounts NetIncomeLossInludesOtherAmounts	882845	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3234647	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	23642745	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26877392	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6773268	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-5179500	usd
CY2022	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	3872175	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	4720214	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-110289179	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-19949	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	44343986	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	70031	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	99746998	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44447249	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-409204	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-88879979	usd
CY2022	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1100000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	28028680	usd
CY2022	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	20194200	usd
CY2022	us-gaap	Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Amortization Expense Period Increase Decrease DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAmortizationExpensePeriodIncreaseDecrease	3872175	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	295000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	278931	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	110299	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45729636	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	405299	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1296906	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3905	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15659	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19564	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1312565	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15659	usd
CY2022Q2	QIND	Control Block Shares Transferred Shares ControlBlockSharesTransferredShares	77669078	shares
CY2022Q2	QIND	Control Block Shares Transferred Value ControlBlockSharesTransferredValue	500000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_z1Z4YeP86zDh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 65.2pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 65.2pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s, impairments and estimations of long-lived assets, revenue recognition of Contract based revenue, allowances for uncollectible accounts, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 2pt 0 4.5pt; text-indent: -0.5pt"> </p>
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37835611	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1794218	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7539940	usd
CY2022Q4	us-gaap	Guaranty Assets GuarantyAssets	344143	usd
CY2022Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	179488	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	123117	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	110289356	usd
CY2022Q4	us-gaap	Cash Cash	1312565	usd
CY2021Q4	us-gaap	Cash Cash	15659	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1202674	usd
CY2022Q4	QIND	Work In Progress WorkInProgress	57433535	usd
CY2022Q4	us-gaap	Margin Deposit Assets MarginDepositAssets	1036019	usd
CY2022Q4	QIND	Retention Receivable RetentionReceivable	2800611	usd
CY2022Q2	QIND	Transfer Of Interst In Investment TransferOfInterstInInvestment	0.51	pure
CY2022Q4	us-gaap	Loans Payable LoansPayable	27898630	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	63090	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	18220315	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	836381	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	31855	usd
CY2022Q4	QIND	Other Liabilities Miscellaneous Current OtherLiabilitiesMiscellaneousCurrent	46162	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	100134714	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102883709	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	94738209	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11216017	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	331609	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	255111	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4843433	usd
CY2022	us-gaap	Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1 DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1	3840320	usd
CY2021	us-gaap	Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1 DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1	4458	usd
CY2022	us-gaap	Depreciation Depreciation	171014	usd

Files In Submission

Name	View Source	Status
0001663577-23-000151-index-headers.html	Edgar Link	pending
0001663577-23-000151-index.html	Edgar Link	pending
0001663577-23-000151.txt	Edgar Link	pending
0001663577-23-000151-xbrl.zip	Edgar Link	pending
ex10_1.htm	Edgar Link	pending
ex10_10.htm	Edgar Link	pending
ex10_11.htm	Edgar Link	pending
ex10_12.htm	Edgar Link	pending
ex10_13.htm	Edgar Link	pending
ex10_14.htm	Edgar Link	pending
ex10_15.htm	Edgar Link	pending
ex10_16.htm	Edgar Link	pending
ex10_2.htm	Edgar Link	pending
ex10_3.htm	Edgar Link	pending
ex10_4.htm	Edgar Link	pending
ex10_5.htm	Edgar Link	pending
ex10_6.htm	Edgar Link	pending
ex10_7.htm	Edgar Link	pending
ex10_8.htm	Edgar Link	pending
ex10_9.htm	Edgar Link	pending
ex14_2.htm	Edgar Link	pending
ex21_1.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex4_3.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
image_016.jpg	Edgar Link	pending
image_017.jpg	Edgar Link	pending
image_018.jpg	Edgar Link	pending
image_019.jpg	Edgar Link	pending
image_027.jpg	Edgar Link	pending
image_029.gif	Edgar Link	pending
image_030.jpg	Edgar Link	pending
image_031.jpg	Edgar Link	pending
image_032.gif	Edgar Link	pending
image_036.jpg	Edgar Link	pending
image_037.gif	Edgar Link	pending
image_037.jpg	Edgar Link	pending
image_038.jpg	Edgar Link	pending
image_039.jpg	Edgar Link	pending
image_040.jpg	Edgar Link	pending
image_041.jpg	Edgar Link	pending
image_042.gif	Edgar Link	pending
image_042.jpg	Edgar Link	pending
image_043.jpg	Edgar Link	pending
image_044.jpg	Edgar Link	pending
image_045.jpg	Edgar Link	pending
image_046.jpg	Edgar Link	pending
image_047.jpg	Edgar Link	pending
image_048.jpg	Edgar Link	pending
image_049.jpg	Edgar Link	pending
image_050.jpg	Edgar Link	pending
image_051.jpg	Edgar Link	pending
image_052.jpg	Edgar Link	pending
image_053.jpg	Edgar Link	pending
image_054.jpg	Edgar Link	pending
image_055.jpg	Edgar Link	pending
image_056.jpg	Edgar Link	pending
image_057.jpg	Edgar Link	pending
image_058.jpg	Edgar Link	pending
image_065.jpg	Edgar Link	pending
image_101.jpg	Edgar Link	pending
image_102.jpg	Edgar Link	pending
image_103.jpg	Edgar Link	pending
image_104.jpg	Edgar Link	pending
image_105.jpg	Edgar Link	pending
image_106.jpg	Edgar Link	pending
image_107.jpg	Edgar Link	pending
image_108.jpg	Edgar Link	pending
image_109.jpg	Edgar Link	pending
image_110.jpg	Edgar Link	pending
image_111.jpg	Edgar Link	pending
image_112.jpg	Edgar Link	pending
image_113.jpg	Edgar Link	pending
image_114.jpg	Edgar Link	pending
image_115.jpg	Edgar Link	pending
image_116.jpg	Edgar Link	pending
image_117.jpg	Edgar Link	pending
image_118.jpg	Edgar Link	pending
image_119.jpg	Edgar Link	pending
image_120.jpg	Edgar Link	pending
image_121.jpg	Edgar Link	pending
image_122.jpg	Edgar Link	pending
image_123.jpg	Edgar Link	pending
image_124.jpg	Edgar Link	pending
image_125.jpg	Edgar Link	pending
image_126.jpg	Edgar Link	pending
image_127.jpg	Edgar Link	pending
image_128.jpg	Edgar Link	pending
image_129.jpg	Edgar Link	pending
image_130.jpg	Edgar Link	pending
image_131.jpg	Edgar Link	pending
image_132.jpg	Edgar Link	pending
image_133.jpg	Edgar Link	pending
image_134.jpg	Edgar Link	pending
image_135.jpg	Edgar Link	pending
image_136.jpg	Edgar Link	pending
image_137.jpg	Edgar Link	pending
image_138.jpg	Edgar Link	pending
image_139.jpg	Edgar Link	pending
image_140.jpg	Edgar Link	pending
image_141.jpg	Edgar Link	pending
image_142.jpg	Edgar Link	pending
image_143.jpg	Edgar Link	pending
image_144.jpg	Edgar Link	pending
image_145.jpg	Edgar Link	pending
image_146.jpg	Edgar Link	pending
image_147.jpg	Edgar Link	pending
image_148.jpg	Edgar Link	pending
image_149.jpg	Edgar Link	pending
image_150.jpg	Edgar Link	pending
image_151.jpg	Edgar Link	pending
image_152.jpg	Edgar Link	pending
image_153.jpg	Edgar Link	pending
image_154.jpg	Edgar Link	pending
image_155.jpg	Edgar Link	pending
image_156.jpg	Edgar Link	pending
image_157.jpg	Edgar Link	pending
image_158.jpg	Edgar Link	pending
image_159.jpg	Edgar Link	pending
image_160.jpg	Edgar Link	pending
image_161.jpg	Edgar Link	pending
image_162.jpg	Edgar Link	pending
image_221.jpg	Edgar Link	pending
image_222.jpg	Edgar Link	pending
image_223.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qind-20221231.xsd	Edgar Link	pending
qind10k123122.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
qind-20221231_cal.xml	Edgar Link	unprocessable
qind-20221231_def.xml	Edgar Link	unprocessable
qind-20221231_pre.xml	Edgar Link	unprocessable
qind-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
qind10k123122_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QIND
Quality Industrial Corp. Stock $qind

2023 Q1 Form 10-K Financial Statement

#000166357723000151 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QIND Quality Industrial Corp. Stock $qind

2023 Q1 Form 10-K Financial Statement

#000166357723000151 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QIND
Quality Industrial Corp. Stock $qind